After a stunning share price run, 4D Medical has plenty of believers and sceptics. CEO Dr Andreas Fouras makes the case for ...
Global X's Justin Lin on how supply and demand tailwinds are combining to drive a commodities supercycle and why ETFs are the ...
After a stunning share price run, 4D Medical has plenty of believers and sceptics. CEO Andreas Fouras makes the case for what ...
Perhaps that's no surprise, given September is famously the worst month of the year for the ASX 200 from a performance ...
While the super cycle bear market in bonds – or rising trend in yields - likely has further to go with spikes and setbacks ...
The continual innovation in the finance business is part of the reason home prices rose so much, part of the reason for annual credit card fees, part of the reason the engagement of women in the ...
Challenger IM’s Stephen Martin on how investing across a mixture of public and private credit assets helps maximise returns ...
The danger of when benchmark awareness becomes benchmark dependence and why we must measure dollar performance for client ...
James Gerrish reveals why he's overweight commodities, the lithium stock he just bought, and why a Westpac special dividend ...
Reporting season is done and dusted. In this episode of Buy Hold Sell, we assess the standouts and casualties at the top end ...
Sorting the solid from the soft from reporting season, Forager's Steve Johnson and Seneca's Ben Richards give their verdicts.
Cash has been hard to beat. Muzinich’s Ian Horn explains why today’s yields could make short-dated credit an attractive next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results